| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/05/2009 | US20090062229 Method and composition for reducing the expression of rock-ii |
| 03/05/2009 | US20090062228 piRNA and uses related thereto |
| 03/05/2009 | US20090062227 Methods and compositions for inducing apoptosis by stimulating er stress |
| 03/05/2009 | US20090062226 Method and Compositions for Inhibiting MAGE Protein Interaction With KAP-1 |
| 03/05/2009 | US20090062225 Double-stranded ribonucleic acid (dsRNA), and its use in mediating RNA interference to inhibit the expression of one of the genes of the JC virus and the use of the dsRNA to treat pathological processes mediated by JC virus infection, such as PML; sense, antisense |
| 03/05/2009 | US20090062224 Therapeutic use of cpg oligodeoxynucleotide for skin disease |
| 03/05/2009 | US20090062223 Amino tricyclic-nucleoside compounds, compositions, and methods of use |
| 03/05/2009 | US20090062222 Methods for Sensitizing Cancer Cells to Inhibitors |
| 03/05/2009 | US20090062221 Azithromycin for treatment of skin disorders |
| 03/05/2009 | US20090062220 Deuterium-enriched azithromycin |
| 03/05/2009 | US20090062219 Drugs for the treatment and/or prophylaxis of gastroparesis symptom |
| 03/05/2009 | US20090062218 Macrolone compounds |
| 03/05/2009 | US20090062217 Promoter For The Production Of Hyaluronic Acid Containing Ginsenoside Compound K |
| 03/05/2009 | US20090062216 Butanol extract of bidens pilosa |
| 03/05/2009 | US20090062215 Application of d-psicose to suppression of abnormal circadian increase in blood glucose level |
| 03/05/2009 | US20090062214 Left-Side Glucose Lipid a Analogue |
| 03/05/2009 | US20090062204 Compositions and methods for treating and preventing gastroenteric diseases |
| 03/05/2009 | US20090062199 Nogo Receptor Polypeptides and Polypeptide Fragments and Uses Thereof |
| 03/05/2009 | US20090062196 Compositions and methods of treating cancer |
| 03/05/2009 | US20090062191 Composition for maintaining gastrointestinal homeostasis |
| 03/05/2009 | US20090062190 Transcriptional Regulation of Cytokines by LITAF and STAT (6)(B) |
| 03/05/2009 | US20090062189 Tumor suppressor protein and nucleotide encoding same |
| 03/05/2009 | US20090062179 determining whether a cancer cell is sensitive to endocrine therapy by detecting the presence of binding of Deleted in Breast Cancer-1 (DBC-1) and Estrogen Receptor alpha (ER alpha ) |
| 03/05/2009 | US20090062133 Expression analysis of FKBP54 in the diagnosis and treatment of prostate cancer |
| 03/05/2009 | US20090061048 Delivery and controlled release of encapsulated lipophilic nutrients |
| 03/05/2009 | US20090061031 Compositions and methods for treating obesity, obesity related disorders and for inhibiting the infectivity of human immunodeficiency virus |
| 03/05/2009 | US20090061026 Nutraceutic preparation in powder form containing free plant sterols |
| 03/05/2009 | US20090061025 Compositions and methods for treating demodex infestations |
| 03/05/2009 | US20090061024 Compositions and methods employing nmda antagonists for achieving an anesthetic-sparing effect |
| 03/05/2009 | US20090061023 Nutritional supplement |
| 03/05/2009 | US20090061020 Brimonidine Compositions for Treating Erythema |
| 03/05/2009 | US20090061010 Cancer cell targeting using nanoparticles |
| 03/05/2009 | US20090061009 Composition and Method of Treatment of Bacterial Infections |
| 03/05/2009 | US20090061008 Fiber/granule complex for treatment of the gi tract |
| 03/05/2009 | US20090061007 Pharmaceutical preparation |
| 03/05/2009 | US20090061005 Paliperidone Polymorphs |
| 03/05/2009 | US20090060997 Process for producing a pharmaceutical preparation for therapeutic treatment of endometriosis containing a combination of a gestagen and (6s)-5-methyltetrahydrofolate |
| 03/05/2009 | US20090060996 Formulations of Clopidogrel Bisulphate |
| 03/05/2009 | US20090060994 Controlled release azithromycin solid dosages forms |
| 03/05/2009 | US20090060993 Solid pharmaceutical composition for enhanced delivery of coenzyme q-10 and ubiquinones |
| 03/05/2009 | US20090060991 Glutathione based delivery system |
| 03/05/2009 | US20090060990 Nsaid formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery |
| 03/05/2009 | US20090060989 Nsaid formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery |
| 03/05/2009 | US20090060988 Nell-1 enhanced bone mineralization |
| 03/05/2009 | US20090060987 Devices, systems and methods for improving memory and/or cognitive function through brain delivery of sirna |
| 03/05/2009 | US20090060986 Transdermal delivery systems |
| 03/05/2009 | US20090060983 Method And Composition For Making An Orally Disintegrating Dosage Form |
| 03/05/2009 | US20090060982 Methods and devices for the sustained release of multiple drugs |
| 03/05/2009 | US20090060980 Glycan binding proteins as therapeutic targets for retinal disorders and treatment methods based thereon |
| 03/05/2009 | US20090060977 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
| 03/05/2009 | US20090060973 Compositions and methods for coating medical implants |
| 03/05/2009 | US20090060970 Compositions and methods of administering paclitaxel with other drugs using medical devices |
| 03/05/2009 | US20090060968 Inhibitors of phosphatases |
| 03/05/2009 | US20090060949 Flu vaccines and methods of use thereof |
| 03/05/2009 | US20090060948 Cationic lipid-mediated enhancement of nucleic acid immunization of cats |
| 03/05/2009 | US20090060941 Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols |
| 03/05/2009 | US20090060937 Immunostimulatory oligonucleotides and uses thereof |
| 03/05/2009 | US20090060931 Pharmaceutical composition for treating or preventing ovarian cancer |
| 03/05/2009 | US20090060929 Gene therapy and vaccination; non-viral transfection complex of a nucleic acid, optionally, a lipid,a polycationic nucleic acid-binding component, and a cell surface receptor binding peptide of given sequence |
| 03/05/2009 | US20090060927 Pharmaceutical compositions comprising a polynucleotide and optionally an antigen especially for vaccination |
| 03/05/2009 | US20090060922 Acetamide Stereoisomer |
| 03/05/2009 | US20090060917 methyl [2-hydroxy-5-[1-hydroxy-2-[[(2-(4-hydroxyphenyl)-1-methylethyl]amino]ethyl]-phenyl] carbamate; water-stable, long acting beta 2-selective adrenoceptor agonist useful as a bronchodilator in the treatment of bronchoconstriction associated with reversible obstructive airways diseases and the like |
| 03/05/2009 | US20090060915 Polypeptide, vaccine and use thereof |
| 03/05/2009 | US20090060912 Small molecule pi 3-kinase inhibitors and methods of their use |
| 03/05/2009 | US20090060911 Enhancement of antibody-mediated immune responses |
| 03/05/2009 | US20090060905 Use of 15-Lipoxygenase Inhibitors for Treating Obesity |
| 03/05/2009 | US20090060903 administering Noggin proteins to reduce teratogenicity of antineoplastic agents; antibodies |
| 03/05/2009 | US20090060898 Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response |
| 03/05/2009 | US20090060896 Gene repair involving in vivo excision of targeting DNA |
| 03/05/2009 | US20090060889 Ii-RNAi involved Ii suppression in cancer immunotherapy |
| 03/05/2009 | US20090060888 Regulated transcription of targeted genes and other biological events |
| 03/05/2009 | US20090060883 Composition for promotion of bone growth and maintenance of bone health |
| 03/05/2009 | US20090060881 Gamma secretase inhibitor for treatment of herpesvirus infection |
| 03/05/2009 | US20090060879 Oral Compositions, Products and Methods Of Use |
| 03/05/2009 | US20090060876 Orally Used Compatible Solutes Containing Agents |
| 03/05/2009 | US20090060874 Bicyclic pyrrolidine derivatives |
| 03/05/2009 | US20090060873 Novel synthetic triterpenoids and methods of use in the treatment and prevention of multiple scleroris |
| 03/05/2009 | US20090060872 Phosphadiazine hcv polymerase inhibitors v |
| 03/05/2009 | US20090060871 Administration of agonist-antagonist in opioid-dependent patients |
| 03/05/2009 | US20090060870 for treatment of virally induced intraepithelial neoplasias of the ano-genital tract, such as human papilloma virus-induced vulvar-, cervical-, vaginal-, penile- and anal intraepithelial neoplasias; measuring or detecting the presence of a CD4+ type 1 T helper (Th1) cell response against an HPV |
| 03/05/2009 | US20090060867 Phosphadiazine hcv polymerase inhibitors iii and vi |
| 03/05/2009 | US20090060866 Phosphadiazine hcv polymerase inhibitors i and ii |
| 03/05/2009 | US20090060865 Mammalian receptor proteins; related reagents and methods |
| 03/05/2009 | US20090060854 Dermatological Compound |
| 03/05/2009 | US20090060853 Aminophenylbenzothiazole compounds |
| 03/05/2009 | US20090060852 Compounds, Formulations and Methods for Reducing Skin Wrinkles, Creasing and Sagging |
| 03/05/2009 | US20090060851 Use of idebenone for the preparation of a topically-applied depigmentation composition and corresponding composition |
| 03/05/2009 | US20090060848 Pharmaceutical composition which reduces or eliminates drug abuse potential |
| 03/05/2009 | US20090060838 Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies |
| 03/05/2009 | DE202008016832U1 Zusammensetzung zur Behandlung von entzündlichen Erkrankungen des Mund- und Rachenraums Composition for the treatment of inflammatory diseases of the mouth and throat |
| 03/05/2009 | DE202008016517U1 Wässrige Zusammensetzung enthaltend Dexpanthenol und Natriumchlorid An aqueous composition containing panthenol and sodium chloride |
| 03/05/2009 | DE102007041657A1 Markersequenzen für Multiple Sklerose und deren Verwendung Marker sequences for multiple sclerosis and their use |
| 03/05/2009 | DE102007041475A1 Wirkstoffkombination aus Glycyrrhetinsäure und Erythrulose und kosmetische oder dermatologische Zubereitungen, diese Wirkstoffkombination enthaltend Active ingredient combination of glycyrrhetinic acid and Erythrulose and cosmetic or dermatological preparations, this drug combination containing |
| 03/05/2009 | DE102007041473A1 Use of glycyrrhetinic acid and/or glycyrrhizin for manufacturing cosmetic or dermatological preparations to strengthen the natural skin tanning, treat skin and hair and reduce wrinkles |
| 03/05/2009 | DE102007041116A1 1,3-Dihydro-isoindolderivate 1,3-dihydro-isoindolderivate |
| 03/05/2009 | DE102007041115A1 Thiadiazinonderivate Thiadiazinonderivate |
| 03/05/2009 | DE102007040615A1 Osmolyte zur Behandlung von allergisch oder viral bedingten Atemwegserkrankungen Osmolytes for treating allergic or viral respiratory diseases |
| 03/05/2009 | DE102007040336A1 Neue Inhibitoren der 5-Lipoxygenase und deren Verwendungen New inhibitors of 5-lipoxygenase and their uses |
| 03/05/2009 | CA2844647A1 Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells |
| 03/05/2009 | CA2735166A1 Compositions of asymmetric interfering rna and uses thereof |